What role does Homocystein play in menopause?

Homocysteine is a sulfur-containing amino acid; elevated blood levels (hyperhomocysteinemia) are considered an independent risk factor for cardiovascular disease. During menopause, declining estrogen levels can lead to a rise in homocysteine because estrogen supports the activity of enzymes that break down homocysteine. Elevated homocysteine in menopause is associated with increased cardiovascular risk, and possibly with bone density loss and cognitive decline. However, the evidence is moderate, based largely on observational studies. Randomized controlled trials show that supplementation with folic acid, vitamin B12, and B6 effectively lowers homocysteine, but this does not consistently translate into reduced clinical events like heart attacks or strokes. Thus, homocysteine is a useful biomarker for cardiovascular risk assessment in menopause, but not a standalone diagnostic or therapeutic target. MyBody-X tests do not measure homocysteine directly; this requires a blood test. If levels are high, medical consultation is advised before starting any supplementation.